{
  "items": [
    {
      "title": "Amgen: Strong Fundamentals But Expensive Valuation Justifies A Hold",
      "description": "Article analyzes Amgen's strong clinical progress and financials, recommending caution due to valuation and technical indicators.",
      "published_utc": "2025-01-05T22:22:27",
      "source": "SeekingAlpha",
      "url": "https://finnhub.io/api/news?id=d6e2bada4590e6cb2a8a0f476dcec9117273e7206fb178f2a5f2430389dceffb",
      "category": "company",
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323875427/image_1323875427.jpg?io=getty-c-w1536",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 132279730,
      "datetime": 1736086947
    }
  ]
}